LIFE LOOKS BETTER TOWARDS THE END
The soundness of advanced care directives has been undermined by two recent studies in the Archives of Internal Medicine. One research team found that the people designated by patients to make decisions for them “incorrectly predict patients’ end-of-life treatment preferences in one-third of cases”. Even if the surrogates were appointed by the patient or had discussed treatment preferences with them, they were no more accurate.
Another report found that some patients become more tolerant of discomfort, disability and pain as their condition worsens and as time goes on. Furthermore, they cannot accurately predict how they will feel when they are actually confronted with a deterioration in their health. “These changes pose a challenge to advance care planning, which asks patients to predict their future treatment preferences,” say the authors.
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...